-nil
Drugs that act at the benzodiazepine site.
- Drugs ending in -nil: 16
- Approved somewhere: 5
- With a US drug page: 3
- Stem
- -nil
- Class
- Drugs that act at the benzodiazepine site
- Sub-stem of
- -azenil: Drugs that act on the benzodiazepine site, either blocking or activating it
Approved and clinical-stage drugs in ChEMBL whose names ending in -nil, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Armodafinil | Approved | SLC6A3 | Dopamine transporter inhibitor |
| Diphemanil | Approved | CHRM3, CHRM1 | Muscarinic acetylcholine receptor M3 antagonist |
| Modafinil | Approved | SLC6A3 | Dopamine transporter inhibitor |
| Proguanil | Approved | Bifunctional dihydrofolate reductase-thymidylate synthase | Dihydrofolate reductase inhibitor |
| Treprostinil | Approved | PTGIR | Prostanoid IP receptor agonist |
| Asoprisnil | Phase 3 | PGR | Progesterone receptor modulator |
| Chlorproguanil | Phase 3 | — | — |
| Sorbinil | Phase 3 | AKR1B1 | Aldose reductase inhibitor |
| Adrafinil | Phase 2 | — | — |
| Basmisanil | Phase 2 | — | — |
| Cycloguanil | Phase 2 | Bifunctional dihydrofolate reductase-thymidylate synthase | Dihydrofolate reductase inhibitor |
| Emapunil | Phase 2 | TSPO | Translocator protein agonist |
| Padsevonil | Phase 2 | GABA-A receptor; anion channel, Synaptic vesicle protein | GABA-A receptor; anion channel partial agonist |
| Treprostinil palmitil | Phase 1 | — | — |
| Treprostinil phosphate | Phase 1 | — | — |
| Cyclofenil | — | ESR1, ESR2 | Estrogen receptor modulator |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO